SLC43A1 and ovarian cancer: Upon immunoblot analysis, we observed that loss of LAT3 expression was associated with increased oxaliplatin resistance (Fig. 5B), leading us to hypothesize that LAT3 may play a role in oxaliplatin resistance in ovarian cancer as well.